Moderna, Novavax Developing Combined Single-Dose COVID-19 and Influenza Vaccine

Moderna, Novavax Developing Combined Single-Dose COVID-19 and Influenza Vaccine

American pharmaceutical and biotechnology company Moderna, Inc., which partnered with the U.S. National Institutes of Allergy and Infectious Diseases (NIAID) to develop an mRNA COVID-19 vaccine being distributed in the United States under an Emergency Use Authorization (EUA) announced that it is developing a combined single-dose booster vaccine for COVID-19 and seasonal influenza.1 In a […]